FDA仿制藥費用(GDUFA)支付(中英文)

1、以下內(nèi)容原文FDA官網(wǎng)網(wǎng)址：http：/wwwfdagov/Forlndustry/UserFees/GenericDrugUserFees/ucm322629htmGenericDrugUserFeeCoverSheetandPaymentInformation仿制藥費用封面頁和支付信息TheGenericDrugUserFeeAmendmentsof2012authorizesFDAtoassessandcollectuserfeesforhumangenericdrugapplications,certainapplicationsupplements,andrelatedmanufac

2、turers.FormFDA3794,alsoknownastheGenericDrugUserFeeCoverSheetorGDUFACoverSheet,isdesignedtocollecttheminimumnecessaryinformationtodeterminethetotalapplicableuserfeerequiredandtohelpFDAtracktheuserfeepayments.Furthermore,FDAsreviewofagenericdrugsubmissioncannotbeginuntilallrelevantuserfeeobligationsh

3、avebeensatisfied.2012仿制藥用戶費用修正案賦予了FDA權(quán)利評估和收取人用仿制藥申請、特定的申請增補和相關(guān)生產(chǎn)商用戶費用。為此FDA設(shè)計了3794表格，即GDUFA封面頁，用于收集基本信息以決定總的用戶費用，并幫助FDA跟蹤用戶費用的支付。另外，F(xiàn)DA對仿制藥申請的審核只有在相關(guān)的費用支付后才會開始。ATTENTION注意FDAissuesclarificationsforcompletingtheGDUFACoverSheetbyfeetype.Pleaserefertotheappropriatelinkbelowtoobtaintheclarificationinfor

4、mation.FDAwillcontinuetomakeupdatestotheselinksasitidentifiesfurtherinformationthatwillassistthegenericdrugindustryincompletingcoversheets.FDA發(fā)布的關(guān)于填寫GDUFA封面頁的說明是按照費用類型來分的。請參見以下相關(guān)鏈接獲得申明信息。為使更多信息能幫助仿制藥行業(yè)完成封面頁，F(xiàn)DA會繼續(xù)更新這些鏈接。Backlog1(11/16/2012)積壓費AbbreviatedNewDrugApplication(ANDA)(TBD)簡略新藥申請PriorApprov

5、alSupplement(PAS)(TBD)預(yù)批準(zhǔn)變更申請DrugMasterFile(TBD)藥物主文件Facility(TBD)工廠WhenistheGDUFACoverSheetrequired?什么時候需要GDUFA封面頁？TheGDUFACoverSheetisrequiredforeachofthefollowinghumangenericdruguserfees:以下人用仿制藥用戶費用，每個費用均需要一個GDUFA封面頁：Abbreviatednewdrugapplication(ANDA)orapplicableamendment;簡略新藥申請(ANDA)或增補Priorapp

6、rovalsupplement(PAS)orapplicableamendment;預(yù)批準(zhǔn)變更申請(PAS)或增補TypeIIactivepharmaceuticalingredient(API)drugmasterfile(DMF)thatisreferencedonorafterOctober1,2012,inagenericdrugsubmissiontotheFDAandforwhichtheDMFfeehasnotalreadybeenpaid;二類活性藥用成分(API)藥物主文件(DMF)，在2012年10月1日之后(含)被仿制藥申請所引用，尚未支付DMF費用的Genericdru

7、gfacilitywhichisidentifiedorintendedtobeidentifiedinatleastonegenericdrugsubmissionthatispendingorapprovedtoproduceafinisheddosageform(FDF)ofahumangenericdrugoranAPIcontainedinahumangenericdrug;and仿制藥工廠，生產(chǎn)或?qū)⒁a(chǎn)至少一種人用仿制藥制劑，且尚未獲得批準(zhǔn)的，或生產(chǎn)原料藥用于人用仿制藥制劑的，和BacklogANDAwhichispendingonOctober1,2012,andthathas

8、notreceivedatentativeapprovalpriortothatdate.在2012年10月1日因等批準(zhǔn)而積壓的ANDA，和在此日期之前未收到臨時批準(zhǔn)的ANDANote:AcoversheetisnotrequiredforallANDAandPASamendments.ItisonlyapplicabletoanamendmentthatisaddingAPImanufacturinginformationotherthanbyreferencetoaTypeIIDMFwhichissubjecttotheSection744B(a)(3)(F)feeunderGDUFA.注

9、：并不是所有ANDA和PAS增補都需要封面頁。只有當(dāng)增補中包括增加原料藥生產(chǎn)信息而不是引用二類DMF，根據(jù)GDUFA才需要繳納744B(a)(3)(F)費用。HowtofilloutaGDUFACoverSheet?如何填寫GDUFA封面頁？ReadtheinstructionsbelowandthengotoCreateGDUFACoverSheet2tofillouttheform.AGDUFACoverSheetwillbecompletedonlineusingFDAsUserFeeSystemwhichrequirestheuseofMicrosoftInternetExplorer

10、7.0orhigher.先閱讀以下指南，然后登錄CreateGDUFACoverSheet填寫表格，該表格需要使用FDA用戶費用系統(tǒng)在線填寫，需要瀏覽器為微軟IE7.0或更高版本。AccesstheUserFeeSystematCreateGDUFACoverSheet3.登錄CreateGDUFACoverSheet進(jìn)入用戶費用系統(tǒng)。Registeryourorganizationbyprovidinginformationaboutyourorganization.提供組織機構(gòu)的信息注冊你的組織機構(gòu)Createauseraccountforyourorganizationandprovid

11、econtactinformation.為你的組織機構(gòu)創(chuàng)建一個用戶帳號，提供聯(lián)系信息Createacoversheetbyansweringaseriesofquestionsandmakingappropriateselections.依次回答問題，進(jìn)行適當(dāng)?shù)倪x擇，創(chuàng)建一個封面頁Submitthecoversheettocompletetheprocessanddeterminetheuserfeeamountowed.Uponsubmission,aUserFeePaymentI.D.Number(PIN),whichbeginswiththeletters“GD”,isgenerated

12、.ThePINmustbereferencedinyourpaymentsubmission.提交封面頁，完成該過程，確認(rèn)需要支付的用戶費用，會產(chǎn)生一個以“GD”開頭的用戶費用支付ID編號(PIN)。在進(jìn)行支付時，必須注明此PIN編號。AdditionalinstructionsfortheUserFeeSystemandtheprocesstocreateaGDUFACoverSheetcanbelocatedundertheFrequentlyAskedQuestions(FAQs)4withintheUserFeeSystem.Fordetailedinstructionstocompl

13、etetheGDUFACoverSheet,pleaseaccessFormFDA3794-Instructions5.關(guān)于用戶費用系統(tǒng)和創(chuàng)建GDUFA封面頁的過程更多指南可以在用戶費用體系中FrequentlyAskedQuestions(FAQs)上找至U。關(guān)于完成GDUFA圭寸面頁的更多細(xì)節(jié)指南，參見FormFDA3794-InstructionsNote:AsignedcopyofacompletedGDUFACoverSheetmustbeincludedinthefollowingsubmissionstotheFDA:ANDAorPASsubmission(placedinthe

14、firstvolumewithFormFDA356h)andTypeIIAPIDMFsubmission.注：在向FDA提交下述申報資料時，必須附入一份已填寫完成的GDUFA封面頁副本：ANDA或預(yù)批準(zhǔn)變更申請(放在第一卷，F(xiàn)DA356h表格中)和二類原料藥DMF申報。WhatinformationisneededtocompleteaGDUFACoverSheet?要完成GDUFA封面頁，需要哪些信息？GeneralInformation一般信息Name/address/contactinformationofapplicant/holder/owner姓名/地址/申請人、持有人、所有人聯(lián)系

15、信息Name/address/contactinformationofrepresentative/U.S.agent姓名/地址/代表人、美國代理聯(lián)系信息ANDA/PAS簡略新藥申請/預(yù)批準(zhǔn)變更申請ANDAapplicationnumberassignedbyFDA由FDA給定的ANDA申請編號Establishednameofproduct產(chǎn)品名稱Ifapplicable,forSection744B(a)(3)(F)*only如果適用時，僅針對744B(a)(3)(F)(見注)類別Nameofdrugsubstance(s)/API(s)藥用物質(zhì)/原料藥名稱Allfacilitiesinc

16、ludingfacilitysname,address,FEInumber,facilityDUNSnumber,andtheuserfeepaymentIDnumber(ifSection744B(a)(3)(F)feehasalreadybeenpaid)所有工廠，包括工廠名稱、地址、FEI號、工廠鄧氏號，用戶費用支付ID編號(如果744B(a)(3)(F)費用已支付)GDUFArequiresapplicantstopaytheSection744B(a)(3)(F)feeiftheapplicationincludesAPImanufacturinginformationotherth

17、anbyreferencetoaTypeIIDMF.GDUFA要求在申請中包括原料藥生產(chǎn)信息，而非引用二類DMF的申請人支付744B(a)(3)(F)費用。TypeIIAPIDMF二類原料藥DMFDMFnumberassignedbyFDA由FDA給定的DMF編號Drugsubstance/APIname藥用物質(zhì)/原料藥名稱Facility工廠Facilitysname,address,FEInumber,andfacilityDUNSnumber工廠名稱、地址、FEI號、工廠鄧白氏號Confirmationwhetherthefacilitymanufactureshumandrugstha

18、tarenothumangenericdrugs確認(rèn)工廠是生產(chǎn)人用藥，而非人用仿制藥Backlog積壓費ANDAapplicationnumberassignedbyFDAFDA給定的ANDA申請編號Establishednameofproduct產(chǎn)品名稱Howarepaymentssubmitted?如何支付費用？ApaymentmaybesubmittedbyP(electronicpayment),check,bankdraft,U.S.postalmoneyorder,orwiretransfer.Forallpaymentoptions,thepaymentmustbemadeinU

19、.S.currencydrawnonaU.S.financialinstitution.FDArecommendsthatuserfeepaymentsbemadeinatimelymannertomeettherequiredpaymentduedateortobereceivedpriortoanapplicationsubmission.Forapplicationsubmissions,itisrecommendedthatyousendmanualpaymentstothebank4-5businessdaysbeforetheapplicationsubmissionarrives

20、atFDAsothatthereisnodelayinstartingthereviewofyourapplicationsubmission.Pleasefollowtheinstructionsbelowforyourselectedpaymentoption:費用可以通過P(電子支付)、支票、銀行匯票、美國郵政匯票或電匯方式支付。所有支付方式均應(yīng)以美元形式存入一家美國金融機構(gòu)。FDA建議及時支付用戶費用，以免超期，或者保證在申請?zhí)峤磺笆盏礁犊?。提交申報資料時，建議你在申報資料到達(dá)FDA之前4-5天進(jìn)行人工支付，以保證不會延遲對申報的審核。請根據(jù)下列指示選擇付費方式：PaymentOpti

21、ons付費方式Instructions付費步驟P網(wǎng)上在線支付Pisaweb-basedpaymentapplicationthatallowselectronicpaymentstobemadedirectlyfromyourbankaccount.ApaymentcanbeinitiatedaftersubmittingyourcoversheetbyclickingthePayNowbuttonandfollowingtheon-screeninstructionstomakepayment.Topaylater,logintoyourGDUFAUserFeeaccountandacces

22、syourcoversheethistorypagebyclickingonthePreviousCoverSheetsiconatthetopofthepage.ClickthePayNowlinknexttotheUserFeePaymentI.D.Number(PIN)youneedtopayfor.P是一個在線支付工具，可以直接從你的帳號進(jìn)行電子支付。在提交封面頁后，點擊“PayNow”按鈕，根據(jù)屏幕上的提示進(jìn)行支付。如果要稍后支付，則登錄你的GDUFA用戶帳號，點擊頁面頂端PreviousCoverSheets進(jìn)入原來的封面頁，點擊你所需要支付的用戶費用支付ID編號（PIN）旁的“P

23、ayNow”鏈接。PaymentmustbemadepayabletotheFoodandDrugAdministrationandmakereferencetotheUserFeePaymentI.D.Number(PIN).Thepaymentandacopyofyoursignedcoversheetmustbemailedtooneoftheaddressesshownbelow.費用必須付至FDA,并可以索引至用戶費用支付ID號(PIN)。費用與簽字后的封面頁副本必須郵至以下地址之一。Check,BankDraft,orU.S.PostalMoneyOrder支票、銀行匯票或美國郵政

24、匯款Paymentsbymail郵件支付FoodandDrugAdministrationP.O.Box979108St.Louis,MO63197-9000Paymentsbycourier快遞支付U.S.BankAttention:GovernmentLockbox9791081005ConventionPlazaSt.Louis,MO63101Note:ContacttheU.S.Bankat(314)418-4013ifyouhaveanyquestionsconcerningdeliverybycourier.Contactyourfinancialinstitutionandpro

25、videthefollowinginformation:WireTransfer電匯BankName|TelegraphicName:銀行名稱|電信公司名稱U.S.DepartmentofTreasury|TREASNYCBankAddress:銀行地址33LibertyStreet|NewYork,NY10045AccountNumber:帳號75060099RoutingNumber:路由號碼021030004SWIFTNumber:FRNYUS33請與你們的金融機構(gòu)聯(lián)系，并給他們提供以下信息SWIFT代碼Beneficiary:FDA|1350PiccardDrive,Suite200A|Rockville,收款人MD20850Description:Referencet